SecBot SecBot
144 ·Filed Nov 3, 2026

TWST

Twist Bioscience Corp
NEUTRAL
Impact 2/10
Horizonimmediate Processed13d 6h ago SEC0001959173-26-007693
Actionable Insight • Neutral

These are routine tax-covering sales tied to equity vesting, not discretionary portfolio moves. The amounts are immaterial relative to market cap. Monitor for any unexpected increase in insider selling volume or a Form 4 filing showing actual execution.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+5
Entry
$140.30
T+0 close · Nov 3, 2026 · via day close
Latest settled
−5.82%
T+5 · $132.13
Vs SPY
−5.24%
α at T+5
Next horizon
T+20
in 15d
  1. T+0 · Nov 3 $140.30entry
  2. T+1 · 13d ago +1.63%α −0.03% · $142.58
  3. T+5 · 7d ago −5.82%α −5.24% · $132.13
  4. T+9 · todayOpen
  5. T+20 · in 15d Pending
  6. T+60 · in 3mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Two Twist Bioscience officers filed Form 144 notices on November 3, 2026, signaling intent to sell shares. CFO Dennis Cho plans to sell 949 shares (~$128K) and Chief Commercial Officer Patrick Finn plans to sell 2,565 shares (~$347K), both to cover tax obligations from vested equity awards. The sales are small relative to the company's $11.5B market cap and follow a pattern of insider sales over the prior three months.

Key Facts

  • CFO Dennis Cho filed Form 144 to sell 949 shares valued at ~$128,496
  • CCO Patrick Finn filed Form 144 to sell 2,565 shares valued at ~$347,305
  • Both sales are to cover tax obligations from restricted stock vesting on 11/02/2026
  • Cho has sold shares on 7 prior occasions since August 2026 totaling ~$5.6M
  • Finn has sold shares on 5 prior occasions since August 2026 totaling ~$15.2M
  • The proposed sale date is 11/03/2026
  • Combined proposed sale value is ~$475,801, or ~0.004% of market cap

Financial Impact

Combined ~$475,801 in proposed insider sales, representing ~0.004% of $11.5B market cap

dilution

Risk Factors

  • Form 144 is an intent to sell; actual sales may not occur
  • Both officers have a history of regular selling, reducing the signal value of this filing

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
74% bullish (19 analysts)

Investment Themes

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (TWST), Batch item 10001959173-26-007693
Document: 0001959173-26-007693-index.html0001959173-26-007694
Document: 0001959173-26-007693.txt0001959173-26-007693
144 Filing (TWST), Batch item 40001959173-26-007694
Document: 0001959173-26-007694-index.html0001959173-26-007693
Document: 0001959173-26-007694.txt0001959173-26-007693

Track record

47 reports on TWST

Performance horizon

8 of 11 bullish or bearish reports moved the stock their way by T+20. Best: +55.24% at T+60 after the Aug 3, 2026 report. 10 of 12 went positive at some point.

Filters
  1. Nov 16, 2026today 144 Neutral 2/10 Entry $105.03 Now $111.60 +6.26% settles Dec 15
  2. Nov 16, 2026today 144 Neutral 2/10 Entry $105.16 Now $111.60 +6.12% settles Dec 15
  3. Nov 16, 2026today 144 Neutral 2/10 Entry $104.98 Now $111.60 +6.31% settles Dec 15
  4. Nov 16, 2026today 144 Neutral 2/10 Entry $105.61 Now $111.60 +5.67% settles Dec 15
  5. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $104.03 Now $111.60 +7.28% settles Dec 15
  6. Nov 12, 20264d ago 8-K Bullish 6/10 Entry $114.22 Now $111.60 −2.29% settles Dec 11
  7. Nov 12, 20264d ago SC 13G/A Neutral 2/10 Entry $114.22 Now $111.60 −2.29% settles Dec 11
  8. Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $132.13 Now $111.60 −15.54% settles Dec 9
  9. Nov 5, 202611d ago Insider Cluster Neutral 2/10 Entry $120.79 Now $111.60 −7.61% settles Dec 7
  10. Nov 5, 202611d ago SC 13G/A Neutral 2/10 Entry $120.61 Now $111.60 −7.47% settles Dec 4
Showing 10 of 47

US Market Status

Market Closed · Opens Wed (11h 57m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 3, 2026